Your browser doesn't support javascript.
loading
A rare case: Branch retinal vein occlusion associated with the use of tamoxifen.
Demirci, Nebi Serkan; Erdem, Gokmen Umut; Uçgun, Nil Irem; Bozkaya, Yakup; Ozdemir, Nuriye Yildirim; Dogan, Mutlu; Zengin, Nurullah.
Afiliación
  • Demirci NS; Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
  • Erdem GU; Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
  • Uçgun NI; Department of Ophthalmology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
  • Bozkaya Y; Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
  • Ozdemir NY; Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
  • Dogan M; Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
  • Zengin N; Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkey.
J Cancer Res Ther ; 15(3): 722-724, 2019.
Article en En | MEDLINE | ID: mdl-31169251
ABSTRACT
Tamoxifen-induced ocular complications including cataracts, keratopathies, retinopathy, impaired visual acuity, ocular irritation, optical neuritis, and retinal vein occlusion are uncommonly reported in the literature. Herein, we report on a premenopausal patient with right-side breast carcinoma who received adjuvant tamoxifen therapy (20 mg/day) for 1.5 years and developed sudden visual loss. Fundal examination revealed an obstruction in the branch of the retinal vein. The diagnosis was confirmed by fluorescein angiography and optical coherence tomography. Thus, tamoxifen was switched to an aromatase inhibitor. Tamoxifen-induced ocular complications should be kept in mind when visual symptoms are seen in patients undergoing tamoxifen therapy. In such cases, a complete ocular examination should be performed.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Oclusión de la Vena Retiniana / Antineoplásicos Hormonales Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Año: 2019 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Oclusión de la Vena Retiniana / Antineoplásicos Hormonales Tipo de estudio: Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Año: 2019 Tipo del documento: Article